Health Care: Drugs

Allergan PLC (AGN: NYSE)

$243.86 n/a | n/a%
04/28/17 - 04:01 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 14.57B 12.69B 4.68B 2.60B
Cost of Sales 1.67B 600.20M 1.70B 466.50M
Gross Operating Profit 12.90B 12.09B 2.97B 2.14B
Selling, General, and Administrative Expenses 4.74B 4.48B 2.27B 830.90M
Research & Development 2.58B 2.36B 605.70M 191.30M
Operating Income before D & A (EBITDA) 5.58B 5.25B 98.60M 1.11B
Depreciation & Amortization 6.66B 7.60B 3.83B 1.48B
Interest Income 69.90M 41.60M 8.10M 4.80M
Other Income - Net 219.20M -264.80M -27.30M -18.60M
Special Income / Charges -748.90M -783.60M -730.00M -1.00M
Total Income Before Interest Expenses (EBIT) -1.54B -3.35B -4.48B -383.00M
Interest Expense 1.30B 1.19B 411.80M 239.80M
Pre-Tax Income -2.83B -4.55B -4.89B -622.80M
Income Taxes -1.90B -1.61B -513.60M -155.30M
Minority Interest 6.10M 4.20M 0.00 0.00
Net Income From Continuing Operations -935.00M -2.94B -2.48B -467.50M
Net Income From Discontinued Operations 15.91B 6.86B 854.10M -282.90M
Net Income From Total Operations 14.98B 3.92B -1.63B -750.40M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 14.97B 3.92B -1.63B -750.40M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-186.10M -2.16B -1.75B -466.50M
Preferred Dividends
Net Income Available To Common -1.21B -3.17B -2.48B -467.50M
Basic EPS from Continuing Ops. -3.17 -8.64 -11.31 -3.29
Basic EPS from Discontinued Ops. 41.35 18.65 3.89 -1.98
Basic EPS from Total Operations 38.18 10.01 -7.42 -5.27
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 38.18 10.01 -7.42 -5.27
Basic Normalized Net Income/Share -0.63 -6.34 -7.99 -3.28
EPS fr Continuing Ops. -3.17 -8.64 -11.31 -3.29
EPS fr Discontinued Ops 41.35 18.65 3.89 -1.98
EPS fr Total Ops. 38.18 10.01 -7.42 -5.27
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 38.18 10.01 -7.42 -5.27
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.63 -6.34 -7.99 -3.28
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AGN

Latest AGN Headlines from TheStreet

More Financial News for AGN

Press Releases for AGN

See All Press Releases

Partner Headlines for AGN

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter